Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cooper

Showing results (1481-1490 of 1,657) with videos related to

Pageof 166
Sort By:
Geroscience|October 18, 2023
Immune cell composition varies by age, sex and exposure to social adversity in free-ranging Rhesus MacaquesMitchell R Sanchez Rosado, Nicole Marzan-Rivera, Marina M Watowich, et al.
Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Journal of Medicinal Chemistry|May 31, 2014
Lead optimization of 1,4-azaindoles as antimycobacterial agentsPravin S Shirude, Radha K Shandil, M R Manjunatha, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesisLalgudi S Harikrishnan, Muthoni G Kamau, Timothy F Herpin, et al.
Journal of Medicinal Chemistry|November 21, 1998
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agentF G Njoroge, A G Taveras, J Kelly, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2025
Deep Learning Estimation of Small Airways Disease from Inspiratory Chest CT: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in COPDMuhammad F A Chaudhary, Hira A Awan, Sarah E Gerard, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 1, 2021
Polycythemia is Associated with Lower Incidence of Severe COPD Exacerbations in the SPIROMICS StudyAshraf Fawzy, Han Woo, Aparna Balasubramanian, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2021
Reconsidering the Utility of Race-Specific Lung Function Prediction EquationsAaron D Baugh, Stephen Shiboski, Nadia N Hansel, et al.
Chest|November 21, 2021
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPDCharles R Esther, Wanda K O'Neal, Wayne H Anderson, et al.
Pageof 166

Showing results (1481-1490 of 1,657) with videos related to

Sort By:
Pageof 166
Geroscience|October 18, 2023
Immune cell composition varies by age, sex and exposure to social adversity in free-ranging Rhesus MacaquesMitchell R Sanchez Rosado, Nicole Marzan-Rivera, Marina M Watowich, et al.
Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.
Journal of Medicinal Chemistry|July 1, 2025
Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl TransferaseAmrita Singh, Logan T Zwerneman, Kyle Planck, et al.
Journal of Medicinal Chemistry|May 31, 2014
Lead optimization of 1,4-azaindoles as antimycobacterial agentsPravin S Shirude, Radha K Shandil, M R Manjunatha, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesisLalgudi S Harikrishnan, Muthoni G Kamau, Timothy F Herpin, et al.
Journal of Medicinal Chemistry|November 21, 1998
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agentF G Njoroge, A G Taveras, J Kelly, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2025
Deep Learning Estimation of Small Airways Disease from Inspiratory Chest CT: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in COPDMuhammad F A Chaudhary, Hira A Awan, Sarah E Gerard, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|July 1, 2021
Polycythemia is Associated with Lower Incidence of Severe COPD Exacerbations in the SPIROMICS StudyAshraf Fawzy, Han Woo, Aparna Balasubramanian, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2021
Reconsidering the Utility of Race-Specific Lung Function Prediction EquationsAaron D Baugh, Stephen Shiboski, Nadia N Hansel, et al.
Chest|November 21, 2021
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPDCharles R Esther, Wanda K O'Neal, Wayne H Anderson, et al.
Pageof 166